← All trials
NCT04388410
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2020
- Primary completion
- Oct 31, 2020
- Completion date
- Dec 31, 2020
- First posted
- May 14, 2020
- Last posted
- May 15, 2020
- Enrollment
- 250
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranLead sponsor
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranReponsible party - principal investigator
- Instituto Nacional de Enfermedades RespiratoriasCollaborator
- Instituto Nacional de Cardiologia Ignacio ChavezCollaborator
- Government of ColombiaCollaborator
- Hospital General Dr. Manuel Gea GonzalezCollaborator
- Hospital Regional Alta Especialidad BajioCollaborator
- Hospital San Jose Tec de MonterreyCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.